Loading...

MPH Health Care AG

0W1Q.LLSE
Healthcare
Drug Manufacturers - Specialty & Generic
£19.00
£2.00(11.76%)

MPH Health Care AG (0W1Q.L) Company Profile & Overview

Explore MPH Health Care AG’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

MPH Health Care AG (0W1Q.L) Company Profile & Overview

MPH Health Care AG, an investment company, engages in the healthcare business in Germany. It produces and sells medicinal products for the therapies of cancer, HIV, and other chronic diseases. The company also offers medical aesthetic treatments; and develops and sells pharmaceutical and medical products; and provides related services, as well as medical devices for the aesthetic surgery and cosmetic dermatology. In addition, it is involved in the provision of cytostatic solutions; and real estate activities. The company was formerly known as MPH Mittelständische Pharma Holding AG and changed its name to MPH Health Care AG in 2017. The company was founded in 2008 and is based in Berlin, Germany. MPH Health Care AG is a subsidiary of Magnum AG.

SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
CEOPatrick Brenske

Contact Information

49 30 863 214 560
GrUenauer Strasse 5, Berlin, 12557

Company Facts

2 Employees
IPO DateJan 29, 2018
CountryDE
Actively Trading

Frequently Asked Questions

;